Health CatalystvsMicrosoft

HCAT and MSFT stock compared: price, dividend, valuation and results, from SEC filings.

HCAT

Health Catalyst, Inc

$1.45

Value $107M

-3.97%
HCAT's page

MSFT

Microsoft Corporation

$524.27

Value $3.89T

-0.80%
MSFT's page

Health Catalyst (HCAT) has a market value of $107M and Microsoft (MSFT) $3.89T. Over the last year, with dividends, HCAT moved -36.1% and MSFT +3.2%. Dividend yield: HCAT none, MSFT 0.69%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HCAT$107M

    MSFT$3.89T

    MSFT is 36,485 times HCAT

  • Revenue, 12 months

    HCAT$272M

    MSFT$346B

    MSFT is 1,273 times HCAT

  • Net income, 12 months

    HCAT-$202M

    MSFT$143B

  • Operating margin

    HCAT-65.7%

    MSFT47.1%

    112.8 points apart

  • ROIC

    HCAT-44.9%

    MSFT28.7%

    73.5 points apart

  • P/E

    HCAT–

    MSFT27.3

  • Dividend yield

    HCAT0.0%

    MSFT0.7%

    0.7 points apart

  • 5-year return

    HCAT-97.1%

    MSFT+61.9%

    159.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HCAT-97.1%

MSFT+61.9%

05010015020222023202420252026
Returns by period
PeriodHCATWith dividendsMSFTWith dividends
1 year since November 14, 2025-36.1%Price -36.1%+3.2%Price +2.3%
3 years since November 16, 2023-81.6%-43.1% a yearPrice -81.6%+41.8%+12.3% a yearPrice +38.8%
5 years since November 15, 2021-97.1%-50.6% a yearPrice -97.1%+61.9%+10.1% a yearPrice +55.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HCATHealth CatalystMSFTMicrosoft

Valuation

HCATMSFT
Valuation
Price$1.45$524.27
Market value$107M$3.89T
Enterprise value (EV)$28M$3.93T
P/E–27.3
P/E, 5-year median–35.2
P/B0.78.3
EV/EBIT–24.1
Free cash flow yield24.1%1.5%

Results and growth

HCATMSFT
Results and growth
Revenue, 12 months$272M$346B
Net income, 12 months-$202M$143B
Free cash flow, 12 months$26M$60.0B
Earnings per share, 12 months-$2.85$19.16
Revenue growth, year on year1.5%17.8%
Revenue growth a year, past+10.5%over 5 years+14.6%over 5 years
EPS growth a year, past–+17.4%over 5 years

Margins and returns on capital

HCATMSFT
Margins and returns on capital
Gross margin49.1%67.7%
Operating margin-65.7%47.1%
Net margin-74.2%41.2%
ROIC-44.9%28.7%
ROE-105.0%34.3%

Balance sheet

HCATMSFT
Balance sheet
Cash$79M$64.5B
Total debt$16M$134B
Net debt / EBITDA–0.2
Interest cover–50.6×

Dividends and buybacks

HCATMSFT
Dividends and buybacks
Dividend yield–0.7%
Dividend per share, 12 months–$3.64
Dividend growth a year, past–+10.2%over 5 years
Buyback yield4.7%0.6%
Shareholder yield4.7%1.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HCAT or MSFT

Didn't find what you were looking for?

Ask us
Which is bigger, Health Catalyst or Microsoft?

By market value, Microsoft ($3.89T) is about 36,485.4 times Health Catalyst ($107M), at today's prices.

How did HCAT and MSFT stock do over the last 5 years?

Since November 15, 2021, HCAT's price moved -97.1% and MSFT's +55.4%. With dividends: HCAT -97.1% (-50.6% a year), MSFT +61.9% (+10.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, HCAT or MSFT?

The dividend yield at today's price is none for Health Catalyst and 0.69% for Microsoft. Over the last twelve months they paid – and $3.64 per share.

Which has the higher profit margins, Health Catalyst or Microsoft?

Over the last twelve months, the net margin was -74.2% for Health Catalyst and 41.2% for Microsoft, and the operating margin -65.7% and 47.1%. Revenue was $272M and $346B.

Which is the better investment, Health Catalyst or Microsoft?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.